atenolol has been researched along with Birth Weight in 11 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Birth Weight: The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the effect of atenolol on the outcome of pregnancy in women with essential hypertension." | 9.06 | Atenolol in essential hypertension during pregnancy. ( Butters, L; Kennedy, S; Rubin, PC, 1990) |
| "To investigate the possible harmful effects of early antihypertensive drug therapy with atenolol versus other therapies on pregnancy outcome, we reviewed the records of 398 women referred to our antenatal hypertension clinic between 1980 and 1995." | 7.69 | Effect of atenolol on birth weight. ( Beevers, DG; Beevers, M; Churchill, D; Lip, GY; Shaffer, LM, 1997) |
| "Treatment with atenolol reduced the incidence of preeclampsia from 5 of 28 (18%) to 1 of 28 (3." | 6.69 | Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension. ( Brateng, D; Brown, Z; Easterling, TR; Millard, SP; Schmucker, B, 1999) |
| "To determine the effect of atenolol on the outcome of pregnancy in women with essential hypertension." | 5.06 | Atenolol in essential hypertension during pregnancy. ( Butters, L; Kennedy, S; Rubin, PC, 1990) |
| "To investigate the possible harmful effects of early antihypertensive drug therapy with atenolol versus other therapies on pregnancy outcome, we reviewed the records of 398 women referred to our antenatal hypertension clinic between 1980 and 1995." | 3.69 | Effect of atenolol on birth weight. ( Beevers, DG; Beevers, M; Churchill, D; Lip, GY; Shaffer, LM, 1997) |
| "Increased motor activity and poor performance in the active avoidance test were observed in the offspring of rats treated with dl-propranolol or sotalol during pregnancy, but not with atenolol and d-propranolol." | 3.68 | Behavioral and biochemical studies in rats following prenatal treatment with beta-adrenoceptor antagonists. ( Gitter, S; Gordon, I; Rehavi, M; Speiser, Z, 1991) |
| "Forty term patients with pregnancy-induced hypertension were treated with the beta 1-adrenoceptor blocker atenolol (Tenormin R; ICI) for at least 7 days prior to parturition." | 3.67 | Influence of the beta 1-adrenoceptor blocker atenolol on antenatal cardiotocography. ( Montan, S; Sjöberg, NO; Solum, T, 1984) |
| "Treatment with atenolol reduced the incidence of preeclampsia from 5 of 28 (18%) to 1 of 28 (3." | 2.69 | Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension. ( Brateng, D; Brown, Z; Easterling, TR; Millard, SP; Schmucker, B, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, L | 1 |
| Ng, A | 1 |
| Chen, W | 1 |
| Spencer, HT | 1 |
| Lee, MS | 1 |
| Fuerst, M | 1 |
| Dubois, D | 1 |
| Petitcolas, J | 1 |
| Temperville, B | 1 |
| Klepper, A | 1 |
| Catherine, P | 1 |
| Lardoux, H | 1 |
| Gerard, J | 1 |
| Blazquez, G | 1 |
| Flouvat, B | 1 |
| Montan, S | 1 |
| Solum, T | 1 |
| Sjöberg, NO | 1 |
| Lip, GY | 1 |
| Beevers, M | 1 |
| Churchill, D | 1 |
| Shaffer, LM | 1 |
| Beevers, DG | 1 |
| Ellis, MR | 1 |
| Kane, KY | 1 |
| Easterling, TR | 1 |
| Brateng, D | 1 |
| Schmucker, B | 1 |
| Brown, Z | 1 |
| Millard, SP | 1 |
| Speiser, Z | 1 |
| Gordon, I | 1 |
| Rehavi, M | 1 |
| Gitter, S | 1 |
| Blake, S | 1 |
| MacDonald, D | 1 |
| Butters, L | 1 |
| Kennedy, S | 1 |
| Rubin, PC | 1 |
4 trials available for atenolol and Birth Weight
| Article | Year |
|---|---|
Beta-blockers may have role in preeclampsia.
Topics: Adrenergic beta-Antagonists; Atenolol; Birth Weight; Clinical Trials as Topic; Female; Humans; Hyper | 1982 |
Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Birth Weight; Cardiac Output; Double-Blind Method; Fem | 1999 |
The prevention of the maternal manifestations of pre-eclampsia by intensive antihypertensive treatment.
Topics: Adult; Atenolol; Bendroflumethiazide; Birth Weight; Drug Therapy, Combination; Embryonic and Fetal D | 1991 |
Atenolol in essential hypertension during pregnancy.
Topics: Atenolol; Birth Weight; Blood Pressure; Double-Blind Method; Female; Fetal Growth Retardation; Gesta | 1990 |
7 other studies available for atenolol and Birth Weight
| Article | Year |
|---|---|
Beta-blocker subtypes and risk of low birth weight in newborns.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Atenolol; Birth Weight; California; Fem | 2018 |
Treatment of hypertension in pregnancy with beta-adrenoceptor antagonists.
Topics: Abnormalities, Drug-Induced; Acebutolol; Adrenergic beta-Antagonists; Adult; Apgar Score; Atenolol; | 1982 |
Which beta-blocker in pregnancy-induced hypertension?
Topics: Atenolol; Birth Weight; Ethanolamines; Female; Humans; Hypertension; Infant, Newborn; Labetalol; Pre | 1983 |
Influence of the beta 1-adrenoceptor blocker atenolol on antenatal cardiotocography.
Topics: Apgar Score; Atenolol; Birth Weight; Female; Fetal Heart; Fetal Monitoring; Heart Rate; Humans; Hype | 1984 |
Effect of atenolol on birth weight.
Topics: Analysis of Variance; Anthropometry; Antihypertensive Agents; Atenolol; Birth Weight; Female; Fetal | 1997 |
Atenolol for prevention of preeclampsia.
Topics: Antihypertensive Agents; Atenolol; Birth Weight; Cardiac Output; Double-Blind Method; Female; Humans | 1999 |
Behavioral and biochemical studies in rats following prenatal treatment with beta-adrenoceptor antagonists.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Atenolol; Avoidance Le | 1991 |